GlassScriptPhysician profile
Heide A Rodgers
NPI 1164577300
$5,744.11
in general payments reported to CMS, 2019-2025
54 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $378 · 2021: $279 · 2022: $915 · 2023: $914 · 2024: $1,128 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,414.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $738.30 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $575.50 | 2019-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $374.02 | 2019-2025 | Opdivo, Opdualag |
| Gt Medical Technologies, INC | $326.80 | 2022-2025 | Gammatile, Gammatile |
| Novartis Pharmaceuticals Corporation | $319.03 | 2019-2025 | |
| Celgene Corporation | $305.38 | 2022-2025 | Reblozyl, Pomalyst |
| Daiichi Sankyo INC. | $271.61 | 2022-2025 | Enhertu, Injectafer |
| Adc Therapeutics America, INC. | $213.81 | 2023-2025 | |
| Emd Serono, INC. | $199.34 | 2019-2025 | Bavencio |
| Janssen Biotech, INC. | $172.74 | 2019-2025 | Darzalex, Talvey, Tecvayli |
| Pharmacyclics LLC, An Abbvie Company | $167.15 | 2019-2023 | Imbruvica, Epkinly |
| Genzyme Corporation | $144.45 | 2019-2025 | |
| Gilead Sciences, INC. | $141.34 | 2019-2024 | Trodelvy |
| Seagen INC. | $140.72 | 2020-2023 | Tukysa |
| Astrazeneca Pharmaceuticals LP | $124.87 | 2022-2025 | Enhertu, Lynparza, Imfinzi |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $109.44 | 2022-2025 | Ojjaara, Blenrep |
| Karyopharm Therapeutics INC. | $90.83 | 2023-2025 | Xpovio |
| Kite Pharma, INC. | $86.57 | 2022-2025 | Yescarta |
| Abbvie INC. | $84.33 | 2021-2025 | |
| Pfizer INC. | $83.01 | 2019-2024 | |
| Beigene USA, INC. | $79.77 | 2024-2025 | Tevimbra, Brukinsa |
| Takeda Pharmaceuticals U.S.A., INC. | $75.01 | 2019-2025 | Fruzaqla, Iclusig |
| Stemline Therapeutics INC. | $67.94 | 2023-2025 | Elzonris, Orserdu |
| Astellas Pharma US INC | $63.54 | 2022-2025 | Vyloy |
| Regeneron Healthcare Solutions, INC. | $61.00 | 2025 | Libtayo |
| Rigel Pharmaceuticals, INC. | $57.08 | 2024-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Incyte Corporation | $51.76 | 2023-2025 | Pemazyre, Monjuvi, Jakafi |
| Taiho Oncology, INC. | $50.28 | 2019-2025 | |
| Tempus Ai, INC | $41.93 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.21 | 2019-2025 | Gilotrif |
| Bayer Healthcare Pharmaceuticals INC. | $31.84 | 2024-2025 | |
| Lilly USA, LLC | $29.60 | 2019-2020 | |
| Sobi, INC | $25.38 | 2024 | |
| Exelixis INC. | $24.56 | 2025 | Cabometyx |
| Recordati_rare_diseases_inc. | $24.40 | 2025 | Enjaymo |
| Genentech USA, INC. | $23.77 | 2019 | |
| Legend Biotech USA INC. | $23.60 | 2025 | Carvykti |
| Agios Pharmaceuticals, INC. | $23.22 | 2025 | Pyrukynd |
| Amgen INC. | $23.00 | 2019 | |
| Eisai INC. | $22.75 | 2024 | |
| Geron Corporation | $22.50 | 2025 | Rytelo |
| Immunocore Limited | $21.58 | 2025 | Kimmtrak |
| Corcept Therapeutics | $20.24 | 2025 | Korlym |
| Dendreon Pharmaceuticals LLC | $20.06 | 2025 | Provenge |
| Puma Biotechnology, INC. | $17.95 | 2024 | |
| Clovis Oncology, INC. | $17.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.34 | 2023 | Xarelto |
| Array Biopharma INC | $16.00 | 2025 | Mektovi, Braftovi, Xalkori |
| Sun Pharmaceutical Industries INC. | $15.40 | 2022 | |
| Blueprint Medicines Corporation | $15.27 | 2022 | |
| Cti Biopharma Corp. | $14.95 | 2023 | Vonjo |
| Acrotech Biopharma INC. | $13.93 | 2022 | |
| Dova Pharmaceuticals | $12.99 | 2019 | |
| Secura Bio, INC. | $8.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heide Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.